Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
E

Failure to Follow Medication Administration Standards and Orders

Seattle, Washington Survey Completed on 05-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to provide pharmaceutical services in accordance with professional standards for four residents, resulting in multiple medication management deficiencies. For one resident with a G-tube, a LPN administered ondansetron by mouth despite the physician's order specifying administration via G-tube, and the order itself contained conflicting instructions for route of administration. The LPN did not clarify the order with the provider before administering the medication, contrary to facility expectations. Another resident self-administered a steroid inhaler (Arnuity Ellipta) without staff oversight, kept the inhaler at bedside without a locked box, and did not rinse their mouth after use as required by manufacturer instructions. The resident's medication administration record did not include an order for the inhaler, and staff confirmed that the resident should have had an order and should have been instructed to rinse their mouth after use. A third resident received a steroid inhaler (fluticasone-salmeterol) from a LPN, who did not assist or remind the resident to rinse their mouth after administration, and the physician's order lacked this instruction despite manufacturer guidelines. For a fourth resident with diabetes, a LPN administered insulin using a pen device without priming the pen beforehand, which is necessary to ensure proper dosing. Staff interviews confirmed that insulin pens should be primed before each use and that residents using steroid inhalers should be assisted to rinse their mouths after administration. These actions and omissions were inconsistent with facility policy, pharmacy guidelines, and professional standards of practice.

An unhandled error has occurred. Reload 🗙